Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-28

Clinical Trial Update: Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of MDMA-assisted psychotherapy for post-traumatic stress disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: MAPS Europe B.V. | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2025-01-28